BioSpace News Archive

Sofwave Medical Ltd (TASE: SOFW) today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will provide a corporate update and participate in one-on-one investor meetings at the Needham 23rd Annual Healthcare Conference, to be held virtually from April 8-11, 2024.

Integer Holdings Corporation announced that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time / 8 a.m. Eastern Time on Thursday, April 25, 2024.

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update.

CG Oncology, Inc. announced that three abstracts highlighting cretostimogene will be presented at the American Urological Association Annual Meeting, taking place at Henry B. González Convention Center in San Antonio, TX from May 3-6, 2024.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today reported financial results for the fourth quarter and year ended December 31, 2023, and provided a corporate update.

Labcorp and OPKO Health, Inc. announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.

Verix, a leading AI-powered pharmaceutical commercial operations enhancement platform provider, announced the launch of its “GenAI Database Explorer,” a capability designed to revolutionize the exploration of commercial pharmaceutical data.

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2023 and provided a corporate strategic update.

Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, announced today their participation as a private company in the 23rd Annual Needham Virtual Healthcare Conference on April 8-11, 2024.

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, announces that it will be attending the LSX World Congress and presenting at Bio€quity Europe.